KSR-standard
2 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 23-739 | Jodi A. Schwendimann, fka Jodi A. Dalvey v. Neenah, Inc., et al. | Federal Circuit | 2024-01-09 | Denied | 35-usc-103 federal-circuit-review ksr-standard ksr-v-teleflex obviousness patent-law primary-reference prior-art wbip-v-kohler yeda-v-mylan | Obviousness analysis under 35 U.S.C. § 103 | |
| 23A344 | Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc., et al. | Federal Circuit | 2023-10-17 | Presumed Complete | KSR-standard obviousness patent-law pharmaceutical-patents predictable-result prior-art | Whether the Federal Circuit's obviousness analysis complies with the Supreme Court's standard in KSR International Co. v. Teleflex Inc. by requiring t… |